Resultados de búsqueda - Gitonga, J.

Naturally acquired Rift Valley fever virus neutralizing antibodies predominantly target the Gn glycoprotein por Wright, D., Allen, E.R., Clark, M.H.A., Gitonga, J.N., Karanja, H.K., Hulswit, R.J.G., Taylor, I., Biswas, S., Marshall, J., Mwololo, D., Muriuki, J., Bett, Bernard K., Bowden, T.A., Warimwe, G.M.

Enlace del recurso

Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4–5 June 2024 por Gharpure, R., Vegvari, C., Abdissa, A., Alimi, Y., Anyamba, A., Auerbach, J., Bett, Bernard K., Bird, B.H., Bob, N.S., Breugelmans, J.G., Clark, J., Cleaveland, S., Cramer, J., Dawa, J., Fay, P.C., Formenty, P., Gerdts, V., Gerken, Keli N., Gitonga, J., Groschup, M., Heighway, J., Johnson, S.A.M., Juma, John, Kading, R.C., Kamau, M., Kerama, S., Lubisi, B.A., Lutwama, J., Luyimbazi, D., Marami, D., Moore, S.M., Muturi, M., Mwangoka, G., Ndiu, A., Njenga, M.K., Njouom, R., Nyakarahuka, L., Nzietchueng, S., Oloo, P., Otiende, M., Oyola, Samuel O., Paganini, L.S., Pandit, P.S., Punt, C., Samy, A.M., Situma, S., Sneddon, H., Bosch, Q.A. ten, Tezcan-Ulger, S., Thompson, P.N., Tildesley, M., Tinto, B., Vesga, J.F., Wichgers Schreur, P.P., Hart, P.

Enlace del recurso